CRL logo

CRL Cash From Operations

Annual CFO

$734.58 M
+$50.68 M+7.41%

December 28, 2024

Summary

Performance

1-Year Change

+7.41%

3-Year Change

-3.45%

5-Year Change

+52.74%

15-Year Change

+130.95%

CRL Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.81%
CRL annual cash flow from operations is higher than 93.81% of companies in Healthcare sector

High & Low

All-time High

$760.80 M
CRL annual cash flow from operations is currently -3.45% below its historical high of $760.80 million

3-Year Low

$619.64 M
CRL annual cash flow from operations is currently +18.55% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 28, 2024
CRL previous annual earnings announcement was published on Dec 28, 2024

Next Annual Earnings Report Date

N/A
CRL next annual earnings announcement has not yet been scheduled

OtherCRLcash flowmetrics:

Annual CFI

-$245.09 M
CRL annual cash flow from investing activities is -$245.09 million

Annual CFF

-$550.93 M
CRL annual cash flow from financing activities is -$550.93 million

Annual FCF

$501.61 M
CRL annual free cash flow is $501.61 million

Annual CAPEX

$232.97 M
CRL annual capital expenditures is $232.97 million

Quarterly CFO

$159.36 M
-$92.43 M-36.71%

December 28, 2024

Summary

Performance

3-Month Change

-36.71%

1-Year Change

-17.66%

3-Year Change

-17.66%

5-Year Change

-17.66%

CRL Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.5%
CRL quarterly cash flow from operations is higher than 92.5% of companies in Healthcare sector

High & Low

All-time High

$251.79 M
CRL quarterly cash flow from operations is currently -36.71% below its historical high of $251.79 million

3-Year Low

$102.63 M
CRL quarterly cash flow from operations is currently +55.28% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 28, 2024
CRL previous earnings announcement was published on Dec 28, 2024

Next Quarterly Earnings Report Date

May 9, 2025
CRL next earnings announcement is scheduled for May 9, 2025

OtherCRLcash flowmetrics:

Quarterly CFI

-$76.10 M
CRL quarterly cash flow from investing activities is -$76.10 million

Quarterly CFF

-$75.88 M
CRL quarterly cash flow from financing activities is -$75.88 million

Quarterly FCF

$83.75 M
CRL quarterly free cash flow is $83.75 million

Quarterly CAPEX

$75.62 M
CRL quarterly capital expenditures is $75.62 million

TTM CFO

$734.58 M
-$61.58 M-7.73%

December 28, 2024

Summary

Performance

3-Month Change

-7.73%

1-Year Change

-2.03%

3-Year Change

-2.03%

5-Year Change

-2.03%

CRL TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.91%
CRL TTM cash flow from operations is higher than 93.91% of companies in Healthcare sector

High & Low

All-time High

$796.16 M
CRL TTM cash flow from operations is currently -7.73% below its historical high of $796.16 million

3-Year Low

$614.14 M
CRL TTM cash flow from operations is currently +19.61% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 28, 2024
CRL previous earnings announcement was published on Dec 28, 2024

Next Quarterly Earnings Report Date

May 9, 2025
CRL next earnings announcement is scheduled for May 9, 2025

OtherCRLcash flowmetrics:

TTM CFI

-$245.09 M
CRL TTM cash flow from investing activities is -$245.09 million

TTM CFF

-$550.93 M
CRL TTM cash flow from financing activities is -$550.93 million

TTM FCF

$501.61 M
CRL TTM free cash flow is $501.61 million

TTM CAPEX

$232.97 M
CRL TTM capital expenditures is $232.97 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CRL Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.4%-17.7%-2.0%
3 y3 years-3.5%-17.7%-2.0%
5 y5 years+52.7%-17.7%-2.0%

CRL Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.5%+18.6%-36.7%+55.3%-7.7%+19.6%
5 y5-year-3.5%+52.7%-36.7%+132.3%-7.7%+52.7%
alltimeall time-3.5%+2075.4%-36.7%>+9999.0%-7.7%>+9999.0%

Charles River Laboratories International Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
$734.58 M(+7.4%)
$159.36 M(-36.7%)
$734.58 M(-7.7%)
Sep 2024
-
$251.79 M(+30.1%)
$796.16 M(+6.2%)
Jun 2024
-
$193.53 M(+49.0%)
$749.82 M(+6.4%)
Mar 2024
-
$129.89 M(-41.2%)
$704.40 M(+3.0%)
Dec 2023
$683.90 M(+10.4%)
$220.94 M(+7.5%)
$683.90 M(-2.0%)
Sep 2023
-
$205.45 M(+38.7%)
$697.71 M(+11.6%)
Jun 2023
-
$148.12 M(+35.4%)
$625.04 M(-0.2%)
Mar 2023
-
$109.38 M(-53.4%)
$626.39 M(+1.1%)
Dec 2022
$619.64 M(-18.6%)
$234.76 M(+76.8%)
$619.64 M(+0.9%)
Sep 2022
-
$132.78 M(-11.2%)
$614.14 M(-6.4%)
Jun 2022
-
$149.47 M(+45.6%)
$656.08 M(-5.4%)
Mar 2022
-
$102.63 M(-55.2%)
$693.20 M(-8.9%)
Dec 2021
$760.80 M(+39.2%)
$229.26 M(+31.2%)
$760.80 M(+13.6%)
Sep 2021
-
$174.72 M(-6.4%)
$669.92 M(-0.4%)
Jun 2021
-
$186.59 M(+9.6%)
$672.50 M(+3.7%)
Mar 2021
-
$170.23 M(+23.0%)
$648.21 M(+18.6%)
Dec 2020
$546.58 M(+13.6%)
$138.38 M(-22.0%)
$546.58 M(-7.2%)
Sep 2020
-
$177.30 M(+9.2%)
$588.87 M(+3.8%)
Jun 2020
-
$162.31 M(+136.6%)
$567.42 M(+6.1%)
Mar 2020
-
$68.59 M(-62.0%)
$534.67 M(+11.2%)
Dec 2019
$480.94 M(+9.0%)
$180.68 M(+15.9%)
$480.94 M(+9.2%)
Sep 2019
-
$155.85 M(+20.3%)
$440.23 M(+9.6%)
Jun 2019
-
$129.55 M(+771.9%)
$401.63 M(+1.4%)
Mar 2019
-
$14.86 M(-89.4%)
$395.95 M(-10.2%)
Dec 2018
$441.14 M(+38.7%)
$139.97 M(+19.4%)
$441.14 M(+3.7%)
Sep 2018
-
$117.24 M(-5.4%)
$425.40 M(+15.7%)
Jun 2018
-
$123.87 M(+106.3%)
$367.64 M(+6.7%)
Mar 2018
-
$60.05 M(-51.7%)
$344.57 M(+8.3%)
Dec 2017
$318.07 M(+0.4%)
$124.24 M(+108.9%)
$318.07 M(+1.3%)
Sep 2017
-
$59.48 M(-41.0%)
$313.92 M(-3.7%)
Jun 2017
-
$100.80 M(+200.4%)
$326.08 M(+6.9%)
Mar 2017
-
$33.56 M(-72.1%)
$305.10 M(-3.7%)
Dec 2016
$316.90 M(+3.9%)
$120.08 M(+67.6%)
$316.90 M(-0.1%)
Sep 2016
-
$71.64 M(-10.2%)
$317.14 M(-4.9%)
Jun 2016
-
$79.82 M(+76.0%)
$333.45 M(-1.7%)
Mar 2016
-
$45.35 M(-62.3%)
$339.38 M(+11.3%)
Dec 2015
$304.96 M(+21.5%)
$120.33 M(+36.8%)
$304.96 M(+7.4%)
Sep 2015
-
$87.95 M(+2.6%)
$283.97 M(+8.0%)
Jun 2015
-
$85.74 M(+684.0%)
$262.98 M(+12.3%)
Mar 2015
-
$10.94 M(-89.0%)
$234.19 M(-6.7%)
Dec 2014
$251.05 M(+21.2%)
$99.34 M(+48.3%)
$251.05 M(+17.4%)
Sep 2014
-
$66.96 M(+17.6%)
$213.84 M(-0.0%)
Jun 2014
-
$56.95 M(+104.9%)
$213.89 M(+4.4%)
Mar 2014
-
$27.80 M(-55.3%)
$204.96 M(-1.1%)
Dec 2013
$207.14 M(-0.4%)
$62.12 M(-7.3%)
$207.14 M(-1.1%)
Sep 2013
-
$67.02 M(+39.6%)
$209.53 M(+3.0%)
Jun 2013
-
$48.02 M(+60.2%)
$203.34 M(-4.4%)
Mar 2013
-
$29.97 M(-53.5%)
$212.60 M(+2.3%)
Dec 2012
$207.90 M
$64.51 M(+6.1%)
$207.90 M(-3.5%)
Sep 2012
-
$60.83 M(+6.2%)
$215.43 M(+6.2%)
Jun 2012
-
$57.28 M(+126.6%)
$202.89 M(-3.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
$25.28 M(-64.9%)
$209.21 M(+1.9%)
Dec 2011
$205.28 M(+21.5%)
$72.04 M(+49.2%)
$205.28 M(+2.2%)
Sep 2011
-
$48.29 M(-24.1%)
$200.83 M(+18.0%)
Jun 2011
-
$63.59 M(+197.8%)
$170.17 M(+5.1%)
Mar 2011
-
$21.36 M(-68.4%)
$161.91 M(-4.2%)
Dec 2010
$169.01 M(-24.9%)
$67.59 M(+283.5%)
$169.01 M(+3.3%)
Sep 2010
-
$17.63 M(-68.1%)
$163.58 M(-18.8%)
Jun 2010
-
$55.34 M(+94.4%)
$201.54 M(-6.9%)
Mar 2010
-
$28.46 M(-54.2%)
$216.39 M(-3.8%)
Dec 2009
$225.04 M(-19.6%)
$62.16 M(+11.8%)
$225.04 M(-8.4%)
Sep 2009
-
$55.59 M(-20.8%)
$245.67 M(-5.7%)
Jun 2009
-
$70.18 M(+89.1%)
$260.39 M(-8.8%)
Mar 2009
-
$37.12 M(-55.2%)
$285.38 M(+1.9%)
Dec 2008
$279.95 M(-1.5%)
$82.79 M(+17.7%)
$279.95 M(-10.6%)
Sep 2008
-
$70.31 M(-26.1%)
$313.00 M(-2.1%)
Jun 2008
-
$95.17 M(+200.4%)
$319.87 M(+14.5%)
Mar 2008
-
$31.68 M(-72.6%)
$279.44 M(-1.7%)
Dec 2007
$284.25 M(+72.9%)
$115.84 M(+50.1%)
$284.25 M(+26.2%)
Sep 2007
-
$77.18 M(+41.0%)
$225.16 M(+15.5%)
Jun 2007
-
$54.74 M(+50.0%)
$194.95 M(-2.8%)
Mar 2007
-
$36.49 M(-35.7%)
$200.53 M(+22.0%)
Dec 2006
$164.37 M(-29.9%)
$56.75 M(+20.8%)
$164.37 M(-14.0%)
Sep 2006
-
$46.97 M(-22.1%)
$191.03 M(-11.5%)
Jun 2006
-
$60.32 M(>+9900.0%)
$215.86 M(+6.3%)
Mar 2006
-
$326.00 K(-99.6%)
$203.00 M(-13.5%)
Dec 2005
$234.55 M(+26.9%)
$83.41 M(+16.2%)
$234.55 M(+3.9%)
Sep 2005
-
$71.80 M(+51.3%)
$225.80 M(+15.2%)
Jun 2005
-
$47.46 M(+48.9%)
$195.98 M(+2.7%)
Mar 2005
-
$31.88 M(-57.3%)
$190.85 M(+3.3%)
Dec 2004
$184.83 M(+49.3%)
$74.67 M(+77.9%)
$184.83 M(+23.7%)
Sep 2004
-
$41.97 M(-0.9%)
$149.46 M(+4.8%)
Jun 2004
-
$42.34 M(+63.7%)
$142.66 M(+1.5%)
Mar 2004
-
$25.86 M(-34.2%)
$140.62 M(+13.6%)
Dec 2003
$123.77 M(-7.4%)
$39.29 M(+11.7%)
$123.77 M(-4.2%)
Sep 2003
-
$35.17 M(-12.7%)
$129.14 M(-0.2%)
Jun 2003
-
$40.29 M(+347.5%)
$129.37 M(-4.3%)
Mar 2003
-
$9.00 M(-79.8%)
$135.25 M(+1.2%)
Dec 2002
$133.66 M(+87.5%)
$44.67 M(+26.2%)
$133.66 M(+6.8%)
Sep 2002
-
$35.40 M(-23.3%)
$125.09 M(+17.5%)
Jun 2002
-
$46.18 M(+522.8%)
$106.51 M(+50.3%)
Mar 2002
-
$7.41 M(-79.5%)
$70.88 M(-0.6%)
Dec 2001
$71.30 M(+111.1%)
$36.10 M(+114.7%)
$71.30 M(+48.2%)
Sep 2001
-
$16.82 M(+59.3%)
$48.12 M(+6.7%)
Jun 2001
-
$10.55 M(+34.8%)
$45.11 M(+13.5%)
Mar 2001
-
$7.83 M(-39.4%)
$39.73 M(+17.7%)
Dec 2000
$33.77 M(-10.1%)
$12.92 M(-6.4%)
$33.77 M(+62.0%)
Sep 2000
-
$13.81 M(+166.5%)
$20.85 M(+196.1%)
Jun 2000
-
$5.18 M(+178.4%)
$7.04 M(+278.4%)
Mar 2000
-
$1.86 M
$1.86 M
Dec 1999
$37.57 M(+0.5%)
-
-
Dec 1998
$37.38 M
-
-

FAQ

  • What is Charles River Laboratories International annual cash flow from operations?
  • What is the all time high annual CFO for Charles River Laboratories International?
  • What is Charles River Laboratories International annual CFO year-on-year change?
  • What is Charles River Laboratories International quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly CFO year-on-year change?
  • What is Charles River Laboratories International TTM cash flow from operations?
  • What is the all time high TTM CFO for Charles River Laboratories International?
  • What is Charles River Laboratories International TTM CFO year-on-year change?

What is Charles River Laboratories International annual cash flow from operations?

The current annual CFO of CRL is $734.58 M

What is the all time high annual CFO for Charles River Laboratories International?

Charles River Laboratories International all-time high annual cash flow from operations is $760.80 M

What is Charles River Laboratories International annual CFO year-on-year change?

Over the past year, CRL annual cash flow from operations has changed by +$50.68 M (+7.41%)

What is Charles River Laboratories International quarterly cash flow from operations?

The current quarterly CFO of CRL is $159.36 M

What is the all time high quarterly CFO for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly cash flow from operations is $251.79 M

What is Charles River Laboratories International quarterly CFO year-on-year change?

Over the past year, CRL quarterly cash flow from operations has changed by -$34.17 M (-17.66%)

What is Charles River Laboratories International TTM cash flow from operations?

The current TTM CFO of CRL is $734.58 M

What is the all time high TTM CFO for Charles River Laboratories International?

Charles River Laboratories International all-time high TTM cash flow from operations is $796.16 M

What is Charles River Laboratories International TTM CFO year-on-year change?

Over the past year, CRL TTM cash flow from operations has changed by -$15.24 M (-2.03%)